Cheapest Way to Get Semaglutide Without Insurance

For an FDA-approved product, the lowest published cash price is the oral Wegovy pill at about $149 per month for the 1.5 mg and 4 mg doses through NovoCare Pharmacy (the 4 mg price rises to $199 after August 31, 2026). The injectable pen runs about $199 per month introductory then a standard $349 per month self-pay. New starters on the two lowest pen doses (0.25 mg and 0.5 mg) qualified for $199 per month through March 31, 2026. These are advertised prices that change; confirm current pricing with the manufacturer or pharmacy.

At a retail pharmacy without any program, the list price is high: GoodRx reports Wegovy around $1,349 per month and Ozempic around $1,219 per month for the most common version. Discount-card coupons cut some products sharply, but for the brand-name injectable pens, the manufacturer’s direct NovoCare self-pay program ($199-$499 depending on dose and stage) is usually cheaper than walking into a pharmacy at the cash counter. Verify the current number at your specific pharmacy.

Much less than it was. The FDA declared the semaglutide shortage resolved on February 21, 2025, and the enforcement grace period for compounders ended on April 22, 2025 (503A pharmacies) and May 22, 2025 (503B outsourcing facilities). Large-scale compounding of a copy of approved semaglutide is no longer permitted. Compounded semaglutide may still be dispensed in limited, clinically justified cases (for example, a documented allergy to an inactive ingredient), but it is no longer the broadly available $99-$199 option many people remember. This is information, not legal or medical advice.

On the current NovoCare self-pay menu, yes for the starting dose: the oral Wegovy and Ozempic pill formulations are listed from about $149 per month, while the injectable pens start near $199 per month introductory and settle at a standard $349 per month. The pill and the pen are different products with different dosing and tolerability, so the right choice is clinical, not just price. Discuss which form fits you with a licensed prescriber, and confirm the current price before you start.

Treat unusually low prices as a warning sign. Since late 2025 the FDA has sent dozens of warning letters to sellers marketing GLP-1 medications improperly. Reasonable red flags include claims of “FDA-approved compounded” semaglutide (compounded drugs are not FDA-approved), no licensed prescriber involved, refusal to name the dispensing pharmacy, overseas shipping of injectables, or research-chemical “not for human use” listings. Buy through a licensed US pharmacy or telehealth service with prescriber oversight, and verify before you pay.

A prescription medication used for a diagnosed medical condition is generally an eligible HSA/FSA expense, which can lower the effective cost of paying cash. Eligibility depends on it being prescribed care, not the brand or the pharmacy. Some plans may ask for documentation. Keep your receipt and prescription records, and confirm the specifics with your HSA/FSA administrator before assuming a purchase is reimbursable.